ACTRN12609000969268进行中（未招募）4 期
Comparative Effectiveness and Safety of Juvederm Ultra Plus vs. Restylane Perlane in the Treatment of Subjects with Severe Nasolabial Folds. Phase I and Phase II (Long Term Extension Phase)
Allergan Australia0 个研究点目标入组 75 人开始时间: 2009年11月9日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 30 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. severe nasolabial folds
- •2. No other anti-wrinkle treatment in NLF/mouth region for study duration
- •3. No history of non-ablative resurfacing procedures, dermabrasion, face-lift, photorejuvenation tehniques, or other surgical procedures in lower 2/3 of face & neck
排除标准
- •1. Permanent or semi-permanent implants in lower 2/3 of face
- •2. Facial hair, lesions, inflammation, infection or visual scars in treatment area
- •3. History of connective tissue disease
- •4. Pregnant or breast-feeding
研究者
相似试验
已完成
不适用
Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip AugmentationLip AugmentationNCT01197495Allergan213
已完成
3 期
JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese PopulationTemple HollowingNCT04891419Allergan168
已完成
不适用
JUVÉDERM VOLUMA® to Enhance the Appearance of the Asian NoseAsian Nose EnhancementNCT01846039Allergan29
已完成
3 期
Effect of whitening cream on melasmaChloasmaIRCT2016121031288N2Jarfandishan-e Navid-e Salamat (Janus) knowledge-based company20
已完成
不适用
Safety and Effectiveness of JUVÉDERM™ Injectable Gel With LidocaineNasolabial FoldsNCT00653861Allergan Medical72